Azetidine compounds as orexin receptor antagonists
US7994336B2 · kind B2 · utility
18Cited by
1References
15Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 15, 2007 |
| Grant date | Aug 9, 2011 |
| Priority date | — |
| Expiry date | Nov 6, 2027 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC08L83/10
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to novel azetidine compounds of formula (I), wherein R1, R2, and X are as described in the description and their use as orexin receptor antagonists.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.